Derek is a biomedical research scientist with 20 years of experience.

He developed transgenic technologies to study the embryonic origin of the haematopoietic system at University of Edinburgh. Later, he investigated the role of microRNAs in the pathogenesis of rheumatoid arthritis. Derek discovered the differential targeting of collagen type 1 and 3 by miR-29a. At Causeway, he leads the scientific development of TenoMIR.

Derek has an honorary Senior Lecturer position at the University of Glasgow. He graduated from INSEAD’s Entrepreneurs in Clinical Academia Course and MIT’s Entrepreneurship Development Program. Derek holds a degree in Molecular Biology from University of Glasgow and earned his PhD in Biochemistry and Molecular Biology at the University of Liverpool.